Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model
- 15 March 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (6) , 2079-2087
- https://doi.org/10.1182/blood-2003-06-1770
Abstract
The reduced engraftment potential of hematopoietic stem/progenitor cells (HSPCs) after exposure to cytokines may be related to the impaired homing ability of actively cycling cells. We tested this hypothesis by quantifying the short-term homing of human adult CD34+ cells in nonobese diabetic/severe combined immunodeficient (NOD/SCID) animals. We show that the loss of engraftment ability of cytokine-activated CD34+ cells is associated with a reduction in homing of colony-forming cells (CFCs) to bone marrow (BM) at 24 hours after transplantation (from median 2.8% [range, 1.9%-6.1%] to 0.3% [0.0%-0.7%]; n = 3; P < .01), coincident with an increase in CFC accumulation in the lungs (P < .01). Impaired BM homing of cytokine-activated cells was not restored by using sorted cells in G0G1 or by inducing cell cycle arrest at the G1/S border. Blocking Fas ligation in vivo did not increase the BM homing of cultured cells. Finally, we tested cytokine combinations or culture conditions previously reported to restore the engraftment of cultured cells but did not find that any of these was able to reverse the changes in homing behavior of cytokine-exposed cells. We suggest that these changes in homing and, as a consequence, engraftment result from the increased migratory capacity of infused activated cells, leading to the loss of selectivity of the homing process.Keywords
This publication has 37 references indexed in Scilit:
- Influence of cell cycling and cell division on transendothelial migration of CD34+ cellsBritish Journal of Haematology, 2002
- Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS® (v2·1) and Isolex® 300i (v2·5) clinical scale devicesBritish Journal of Haematology, 2002
- Engraftment potential of human fetal hematopoietic cells in NOD/SCID mice is not restricted to mitotically quiescent cellsBlood, 2002
- Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cellsBlood, 2002
- Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansionExperimental Hematology, 2001
- Early‐acting cytokine‐driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post‐mitotic offspring with preserved engraftment ability in non‐obese diabetic/severe combined immunodeficient miceBritish Journal of Haematology, 2001
- Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primatesJournal of Clinical Investigation, 2001
- Modulation of hematopoietic stem/progenitor cell engraftment by transforming growth factor βExperimental Hematology, 2000
- A Defined Window for Efficient Gene Marking of Severe Combined Immunodeficient-Repopulating Cells Using a Gibbon Ape Leukemia Virus-Pseudotyped Retroviral VectorHuman Gene Therapy, 2000
- Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells.Proceedings of the National Academy of Sciences, 1996